1. Home
  2. KMDA vs DDD Comparison

KMDA vs DDD Comparison

Compare KMDA & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • DDD
  • Stock Information
  • Founded
  • KMDA 1990
  • DDD 1986
  • Country
  • KMDA Israel
  • DDD United States
  • Employees
  • KMDA N/A
  • DDD N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • DDD Computer peripheral equipment
  • Sector
  • KMDA Health Care
  • DDD Technology
  • Exchange
  • KMDA Nasdaq
  • DDD Nasdaq
  • Market Cap
  • KMDA 398.5M
  • DDD 360.4M
  • IPO Year
  • KMDA N/A
  • DDD N/A
  • Fundamental
  • Price
  • KMDA $6.95
  • DDD $3.19
  • Analyst Decision
  • KMDA Strong Buy
  • DDD Buy
  • Analyst Count
  • KMDA 2
  • DDD 2
  • Target Price
  • KMDA $13.00
  • DDD $5.00
  • AVG Volume (30 Days)
  • KMDA 77.7K
  • DDD 4.7M
  • Earning Date
  • KMDA 11-12-2025
  • DDD 11-25-2025
  • Dividend Yield
  • KMDA 2.88%
  • DDD N/A
  • EPS Growth
  • KMDA 27.97
  • DDD N/A
  • EPS
  • KMDA 0.32
  • DDD N/A
  • Revenue
  • KMDA $169,517,000.00
  • DDD $413,342,000.00
  • Revenue This Year
  • KMDA $14.49
  • DDD N/A
  • Revenue Next Year
  • KMDA $10.12
  • DDD $1.78
  • P/E Ratio
  • KMDA $21.01
  • DDD N/A
  • Revenue Growth
  • KMDA 9.67
  • DDD N/A
  • 52 Week Low
  • KMDA $5.43
  • DDD $1.32
  • 52 Week High
  • KMDA $9.16
  • DDD $5.00
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 52.44
  • DDD 54.41
  • Support Level
  • KMDA $6.72
  • DDD $3.01
  • Resistance Level
  • KMDA $7.11
  • DDD $3.29
  • Average True Range (ATR)
  • KMDA 0.19
  • DDD 0.33
  • MACD
  • KMDA 0.03
  • DDD -0.05
  • Stochastic Oscillator
  • KMDA 60.68
  • DDD 35.11

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About DDD 3D Systems Corporation

3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.

Share on Social Networks: